Literature DB >> 310884

Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.

P J Maddison, H Mogavero, M Reichlin.   

Abstract

Forty-three patients were studied whose sera were monospecific for nuclear ribonucleoprotein by double immunodiffusion. Thirty-four patients had features typical of systemic lupus erythematosus of which 30 fulfilled the American Rheumatism Association criteria. Clinical features such as rashes, serositis and hematological abnormalities occurred with a frequency expected in SLE. Raynaud's phenomenon occurred in 60%, but other features of mixed connective tissue disease were uncommon. Clinical evidence of renal disease occurred in only four patients. In our experience a good prognosis is related more to the presence of anti-nRNP alone in the serum than to any specific set of clinical findings.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 310884

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  15 in total

Review 1.  Current management of polymyositis and dermatomyositis.

Authors:  C V Oddis; T A Medsger
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

2.  Overlapping connective tissue diseases in children.

Authors:  D Itzkowitch; M Alexander; J P Famaey; T Appelboom
Journal:  Clin Rheumatol       Date:  1983-12       Impact factor: 2.980

Review 3.  Current perspectives on serological reactions in SLE patients.

Authors:  M Reichlin
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

4.  Clinical and serological features of patients with autoantibodies to GW/P bodies.

Authors:  Rahima A Bhanji; Theophany Eystathioy; Edward K L Chan; Donald B Bloch; Marvin J Fritzler
Journal:  Clin Immunol       Date:  2007-09-17       Impact factor: 3.969

5.  Stimulation of anti-RNP antibody binding to cultured keratinocytes by estradiol.

Authors:  F Furukawa; S Imamura; D A Norris
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

6.  Antinuclear antibodies in routine analysis: the relevance of putative clinical associations.

Authors:  A J Swaak; V Huysen; R J Smeenk
Journal:  Ann Rheum Dis       Date:  1993-02       Impact factor: 19.103

7.  HLA class II genes and antibodies against recombinant U1-nRNP proteins in patients with systemic lupus erythematosus. SLE Study Group.

Authors:  Z Yao; H P Seelig; H Ehrfeld; M Renz; K Hartung; H Deicher; E Keller; C Nevinny-Stickel; E D Albert
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

8.  HLA-DR antigens in systemic lupus erythematosus: association with specificity of autoantibody responses to nuclear antigens.

Authors:  J S Smolen; J H Klippel; E Penner; M Reichlin; A D Steinberg; T M Chused; O Scherak; W Graninger; E Hartter; C C Zielinski
Journal:  Ann Rheum Dis       Date:  1987-06       Impact factor: 19.103

9.  Clinical profiles of patients with antibodies to nuclear ribonucleoprotein.

Authors:  J Calderon; V Rodriguez-Valverde; S Sanchez Andrade; J L Riestra; J Gomez-Reyno
Journal:  Clin Rheumatol       Date:  1984-12       Impact factor: 2.980

10.  Is MCTD a distinct entity? Comparison of clinical and laboratory findings in MCTD, SLE, PSS, and RA patients.

Authors:  L S De Clerck; K A Meijers; A Cats
Journal:  Clin Rheumatol       Date:  1989-03       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.